Previous Article | Next Article 
Journal of Clinical Microbiology, March 1999, p. 748-752, Vol. 37, No. 3
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Multicenter Evaluation of the BACTEC MGIT 960 System for Recovery of Mycobacteria
Bruce A.
Hanna,1,*
Adeleh
Ebrahimzadeh,2
L. Bruce
Elliott,3
Margie A.
Morgan,4
Susan M.
Novak,5
Sabine
Rusch-Gerdes,6
Millie
Acio,4
Denise F.
Dunbar,3
T. Michele
Holmes,3
Charles H.
Rexer,1
Chiminyan
Savthyakumar,2 and
Ann M.
Vannier5
New York University School of Medicine,
Bellevue Hospital,1 and
The City of New
York Department of Health,2 New York,
New York;
Texas Department of Health, Austin,
Texas3;
Cedars-Sinai Medical Center, Los
Angeles,4 and
Kaiser
Permanente, North Hollywood,5 California; and
Forschungszentrum Borstel, Borstel,
Germany6
Received 12 October 1998/Returned for modification 11 November
1998/Accepted 27 November 1998
 |
ABSTRACT |
We evaluated the BACTEC MGIT 960 system, which is a fully
automated, noninvasive system for the growth and detection of
mycobacteria with a capacity to incubate and continuously monitor 960 7-ml culture tubes. We studied 3,330 specimens, 2,210 respiratory and 1,120 nonrespiratory specimens, collected from 2,346 patients treated
at six sites. Processed specimens were inoculated into the BACTEC MGIT
960 and BACTEC 460 TB systems, as well as onto Lowenstein-Jensen slants
and Middlebrook 7H11/7H11 selective plates. From all culture systems, a
total of 362 isolates of mycobacteria were recovered; these were
recovered from 353 specimens collected from 247 patients. The greatest
number of isolates of mycobacteria (289, or 80% of the 362 isolates)
was recovered with the BACTEC MGIT 960, followed by the BACTEC 460 TB
(271, or 75%) and solid media (250, or 69%). From all culture systems
a total of 132 isolates of Mycobacterium tuberculosis
complex were recovered. The greatest number of isolates of M. tuberculosis complex was recovered when liquid medium was
combined with conventional solid media; the number recovered with
BACTEC 460 TB plus solid media was 128 (97%), that recovered with
BACTEC MGIT 960 plus solid media was 121 (92%), that recovered with
BACTEC 460 TB was 119 (90%) and that recovered with all solid media
combined was 105 (79%). The recovery with BACTEC MGIT 960 alone was
102 (77%). The mean times to detection (TTD) for M. tuberculosis complex were 14.4 days for BACTEC MGIT, 15.2 days
for BACTEC 460 TB, and 24.1 days for solid media. The numbers of
isolates of Mycobacterium avium complex (MAC) recovered were 172 (100%) for all systems, 147 (85%) for BACTEC MGIT 960, 123 (72%) for BACTEC 460 TB, and 106 (62%) for all solid media combined.
The TTD for MAC in each system were 10.0 days for BACTEC MGIT 960, 10.4 days for BACTEC 460 TB, and 25.9 days for solid media. Breakthrough
contamination rates (percentages of isolates) for each of the systems
were 8.1% for BACTEC MGIT 960, 4.9% for BACTEC 460 TB, and 21.1% for
all solid media combined.
 |
INTRODUCTION |
The increasing incidence of
tuberculosis and other mycobacterial diseases has made it essential for
laboratories to quickly detect and identify mycobacteria from human
clinical material. When conventional culture media are used, as many as
several weeks of incubation and substantial technical labor may be
necessary for the recovery of organisms. Since it was first introduced, the BACTEC 460 TB system (Becton Dickinson Microbiology Systems, Sparks, Md.) has been the benchmark for rapid detection of
Mycobacterium tuberculosis complex (8, 9). In
recent years, however, a number of new systems which provide similar
times to detection, with fully automated instruments or without the
need for any instrumentation, have been developed. The BACTEC MGIT 960 system is a fully automated, high capacity, nonradiometric, noninvasive
instrument which requires neither needles nor other sharp implements to
simultaneously incubate and monitor 960 7-ml culture tubes. To monitor
microbial growth, the BACTEC MGIT 960 uses the same oxygen-quenching
fluorescent sensor technology as both the manual Mycobacteria Growth
Indicator Tube (BBL MGIT) and the BACTEC 9000MB system, in conjunction
with unique on-board algorithms to determine the positivity of the culture tubes. This multicenter study evaluated the performance of the
BACTEC MGIT 960 as compared to that of the BACTEC 460 TB system as well
as to those of the conventional Lowenstein-Jensen (LJ) and Middlebrook
7H11 solid media for the recovery of mycobacteria from human clinical specimens.
 |
MATERIALS AND METHODS |
Test sites.
Diverse populations of patients treated at six
test sites participated in the study. Three of the sites were health
department laboratories (one metropolitan facility, one state facility,
and one European regional reference center). The other three sites were
a university-based tertiary care medical center, a private medical
center, and a regional reference center.
Specimens.
From among specimens submitted to the
mycobacteriology laboratories at each of the six study sites, 3,330 specimens collected from a total of 2,346 patients were selected at
random. Specimen distribution included 2,210 respiratory and 1,120 nonrespiratory samples. All specimens were digested and decontaminated
according to standard Centers for Disease Control methods
(6). Specimens were processed by the sodium hydroxide and
N-acetyl-L-cysteine (NaOH/NALC) method, with
final concentrations of 1% for NaOH and 0.25% for NALC at five sites
(sites A through E) and 2% for NaOH and 0.25% for NALC at one site
(site F).
AFB smears.
Using the sediment, smears were prepared from
all specimens other than urine and were examined for acid-fast bacteria
(AFB). All AFB smears were either stained with auramine and examined with a fluorescent microscope (five sites) or stained by the Kinyoun method and examined with a light microscope (one site).
Culture medium inoculation, incubation, and test duration.
The remaining sediment was suspended in 1 to 2 ml of sterile
phosphate-buffered saline (pH 6.8) and vortexed for 15 s. This suspension was then used for culture medium inoculation. The order of
inoculation for each of the broth media systems was varied. After all
liquid media were inoculated, 0.1 to 0.25 ml of each processed specimen
was also inoculated onto the surface of an LJ slant and onto each half
of a 7H11/7H11 selective biplate. All culture media were incubated at
37°C, while solid media were incubated in an atmosphere of 5 to 10%
CO2. All liquid medium cultures were tested either until
found to be positive or for 42 days. Solid media were tested for 56 days.
Culture systems. (i) BACTEC MGIT 960.
The BACTEC MGIT 960 culture tube contains 7 ml of Middlebrook 7H9 broth base, to which was
added an enrichment supplement containing oleic acid, albumin,
dextrose, and catalase (BBL MGIT OADC) and an antibiotic mixture of
polymyxin B, amphotericin B, nalidixic acid, trimethoprim, and
azlocillin (BBL MGIT PANTA). After inoculation of each tube with 0.5 ml
of the processed specimen, the tubes were incubated at 37°C in the
BACTEC MGIT 960 instrument and were monitored automatically every 60 min for increase of fluorescence. A series of algorithms included in
the instrument is used to determine presumptive positivity and to alert
the operator to the presence and locations of the positive tubes by
means of indicator lights positioned on the front of the instrument,
tube status displayed on the video display screen, and LEDs positioned at the appropriate tube station. Any sample which was identified as
positive was removed from the instrument, and a smear was prepared and
examined for AFB. Time to detection of mycobacteria was based on the
date of the earliest instrument positivity, which correlated with AFB
smear positivity.
(ii) BACTEC 460 TB.
BACTEC 12B culture vials were prepared
according to the manufacturer's instructions and inoculated with 0.5 ml of the processed specimen. Vials were monitored two to three times
weekly for the first 2 to 3 weeks and then once weekly thereafter
through the sixth week with the BACTEC 460 TB System. Any vial which
was identified as having a growth index (GI) of 10 or greater was
considered presumptively positive and was tested daily until a GI of
50 was observed, whereupon an AFB smear was prepared and examined. For the study, the times to detection (TTD) were based on the first
date that a GI of
50 was found to correlate with AFB smear positivity.
(iii) Solid media.
All specimens were inoculated onto
conventional solid media, which included one LJ slant (BBL) and one
7H11/7H11 selective agar biplate (BBL). For the purpose of data
analysis, the LJ slant and the Middlebrook biplate were regarded as a
single solid-medium system. An individual medium was considered
positive upon appearance of colonies on the surface, and the TTD was
based on the earliest date of detection of colonies on any of the solid
media, ultimately confirmed by positive AFB smear.
Culture protocol.
For all systems, when the first culture
medium of a cohort was identified as positive, an AFB smear (Kinyoun or
Ziehl-Neelsen) was prepared the same day. If this smear was prepared
from a broth medium and it was positive for AFB, the broth was
subcultured. If, however, this smear was prepared from a solid medium
and it was positive for AFB, no further subculture was made. The AFB recovered from solid or liquid media were then identified by the AccuProbe (Gen-Probe, Inc.) culture identification test, high-pressure liquid chromatography, and/or conventional biochemical tests. If, on
the other hand, the AFB smear from any flagged positive medium was
negative, a gram-stained smear was prepared and examined and the result
was noted. If a presumptively positive broth medium was positive for a
bacterium that was not AFB but was negative for AFB, the medium was
considered positive only for breakthrough contaminants and was not
subjected to further testing. At the end of the instrument protocol
period, a terminal AFB smear and subculture to Middlebrook media were
prepared from all instrument-negative liquid media for which any cohort
medium was positive for mycobacteria.
 |
RESULTS |
We compared 3,330 specimens collected from 2,346 patients treated
at the six sites. By all culture systems, a total of 362 isolates of
mycobacteria were recovered from 353 specimens, which had been
collected from 247 patients. The majority of specimens tested (2,210 specimens [66%]) were from the respiratory tract. Overall, 353 (10.6%) of the specimens tested were positive for mycobacteria (Table
1). Among the respiratory specimens, 321 (14.5%) were positive. Mycobacteria were also recovered from 2 (11.1%) of 18 bone marrow specimens, 23 (5.8%) of 395 tissue
specimens, 3 (4.9%) of 61 stool specimens, and 4 (0.9%) of 464 body
fluid specimens. Although 167 urine samples were tested, none were
positive by any medium used in the study.
The numbers of isolates of M. tuberculosis complex,
Mycobacterium avium complex (MAC), and mycobacteria other
than M. tuberculosis (MOTT, not inclusive of MAC) recovered
in each of the culture systems as well as the combined result of
pairing each of the liquid media with solid media are listed in Table
2. Of the 362 isolates recovered during
the study, there were 172 (47.5%) isolates of MAC, 132 (36.5%)
isolates of M. tuberculosis complex, and 58 (16%) isolates
of MOTT recovered by all systems and media. As a single system, the
BACTEC MGIT 960 detected the greatest number of mycobacteria, 289 isolates (80%), followed by the BACTEC 460 TB System, with 271 isolates (75%), and the solid media, with 250 isolates (69%). When
each of the broth medium systems was paired with the solid media and
the combined recovery rates were compared, the same trends were noted.
The BACTEC MGIT 960 plus solid media detected 335 mycobacteria (93%),
as contrasted with 308 mycobacteria (85%) recovered in the BACTEC 460 TB system plus solid media.
View this table:
[in this window]
[in a new window]
|
TABLE 2.
Distribution of isolates recovered in each culture system
and in combinations of solid and liquid systems
|
|
As shown in Table 2, of the 132 isolates of M. tuberculosis
complex recovered during the study, 119 (90%) were detected with the
BACTEC 460 TB System, as contrasted with 105 (79%) detected with solid
media and 102 (77%) detected with the BACTEC MGIT 960. When recovery
on the combined solid media was paired with that on the broth systems,
the BACTEC 460 TB System plus solid media detected 128 (97%) of the
M. tuberculosis isolates as contrasted with 121 (92%)
detected with the BACTEC MGIT 960 plus solid media.
Of the 172 MAC isolates, more were recovered in the BACTEC MGIT 960 (147 isolates, or 86%) than in the BACTEC 460 TB system (123 isolates,
or 72%) and with the combined solid media (106 isolates, or 62%).
When the combined solid media were paired with the broth systems, the
recovery of MAC was also greater with BACTEC MGIT 960 plus solid media
(160 isolates, or 93%) than with the BACTEC 460 TB system plus solid
media (136 isolates, or 79%).
As a single system, the BACTEC MGIT 960 detected 40 (69%) of the 58 isolates of MOTT, whereas 39 (67%) of these isolates were detected
with solid media and only 29 (50%) isolates were detected in the
BACTEC 460 TB system. When the broth systems were paired with the solid
media, the BACTEC MGIT 960 and solid media recovered 54 isolates
(93%), whereas 44 (76%) isolates were found with the BACTEC 460 TB
system and solid media.
As may be expected, there were several instances where one culture
system was scored as contaminated while other media in the cohort were
observed to be positive for AFB. In the present study, this occurred
more often with the BACTEC MGIT 960 than with the other systems. There
were 20 specimens for which mycobacteria were recovered from other
cohort media while only breakthrough contaminants were detected in the
BACTEC MGIT 960 vial. In comparison, there were only eight specimens
for which mycobacteria were recovered in other cohort media while only
breakthrough contaminants were detected in the BACTEC 460 TB System.
During the study, when a culture vessel was found to be positive for
breakthrough contamination, no further examination was performed on the
contaminated medium while the other cohort media were followed to
completion. As shown in Table 3, when
these contaminated cohort specimens are excluded from the analysis, of
331 isolates recovered, the BACTEC MGIT 960 detected 281 (85%)
isolates, followed by the BACTEC 460 TB System, with 251 isolates
(76%), and the solid media, with 233 isolates (70%). When the broth
media systems were paired with the solid media, the BACTEC MGIT 960 plus solid media detected 313 isolates (95%), and 282 isolates (85%)
were recovered in the BACTEC 460 TB system plus solid media. In this
analysis, of the 118 isolates of M. tuberculosis complex
recovered, 108 (92%) were detected with the BACTEC 460 TB System, as
contrasted with 101 isolates (86%) detected with the BACTEC MGIT 960 and 95 isolates (81%) detected with solid media. When the combined
solid media were paired with the broth systems, the BACTEC 460 TB
System plus solid media detected 114 (96%) of the M. tuberculosis isolates, and 111 isolates (94%) were detected with
the BACTEC MGIT 960 plus solid media.
View this table:
[in this window]
[in a new window]
|
TABLE 3.
Distribution of isolates recovered in culture system and
combinations with contaminated cohorts removed from analysis
|
|
The TTD for M. tuberculosis complex and MAC in the BACTEC
MGIT 960 and BACTEC 460 TB systems for the paired isolates (isolates recovered in both systems) and for the nonpaired isolates (total number
of isolates recovered in each test system) are listed in Table
4. When all M. tuberculosis
complex isolates were included in the analysis, the TTD with the BACTEC
MGIT 960 was 14.4 days and that with the BACTEC 460 TB system was 15.2 days. When specimens positive for M. tuberculosis complex
were paired, the TTD were 13.2 days with the BACTEC 460 TB system and
14.4 days with the BACTEC MGIT 960 (P = 0.055, not
significant). The TTD for all MAC isolates in each system were 10.0 days with the BACTEC MGIT 960 and 10.4 days with the BACTEC 460 TB
system. For the paired MAC isolates, the TTD were 9.8 days in the
BACTEC MGIT 960 and 8.4 days in the BACTEC 460 TB System (P = 0.001).
In Table 5, the TTD for M. tuberculosis complex in the BACTEC MGIT 960 and that in the BACTEC
460 TB system for the paired and nonpaired isolates are grouped by
whether the AFB smear result was negative or positive. Among both the
nonpaired and the paired AFB smear-positive specimens, there was very
little difference between the TTD for the BACTEC 460 TB system (10.8 days for nonpaired specimens and 10.3 days for paired specimens) and
the BACTEC MGIT 960 (10.6 days for nonpaired specimens and 10.8 days
for paired specimens). Notably, as can be seen in this table, the
increased number of M. tuberculosis complex isolates
recovered in the BACTEC 460 TB system was due almost exclusively to
recovery from smear-negative samples. This may be a result of random
inoculum distribution, particularly when small numbers of organisms are
present in the original specimen.
View this table:
[in this window]
[in a new window]
|
TABLE 5.
TTD of M. tuberculosis for AFB smear-positive
and smear-negative isolates in BACTEC 960 and 460 TB systems
|
|
Table 6 shows the breakthrough
contamination rates for the BACTEC MGIT 960 and BACTEC 460 TB systems
for specimens collected at all sites in the study. Breakthrough
contamination was defined as the detection of any instrument-positive
tube that was AFB smear negative and subculture negative yet gram-stain
smear positive for other (non-acid-fast) microorganisms. The
contamination rate (percentage of isolates) noted with the BACTEC MGIT
960 was 8.1% (range, 1.8 to 14.6%), while that with the BACTEC 460 TB
system was 4.9% overall (range, 0.9 to 9.2%). As shown in Table 6, at two of the trial sites, the contamination rates for the two systems were similar, while at the other four sites the contamination rate
noted for the BACTEC MGIT 960 was higher than that noted for the BACTEC
460 TB.
The false-positive rate for the BACTEC MGIT 960 was 0.8% and was
calculated as the number of BACTEC MGIT 960 vials which were instrument
positive but were found to be smear negative and subculture negative
for mycobacteria or other bacteria. During the study a total of 351 randomly selected BACTEC MGIT 960 instrument-negative vials (at the end
of the 42-day protocol) were examined by AFB smear and subcultured to
solid media. No false-negative samples from these random terminal
subcultures of instrument-negative tubes were detected during the study.
 |
DISCUSSION |
Following the recent resurgence of tuberculosis in the United
States, the rapid diagnosis of patients with active disease has become
a focus of much interest (1, 11). In addition, MAC has
become the systemic bacterial pathogen most commonly recovered from
patients with AIDS and is an increasingly recognized pulmonary pathogen
in nonimmunocompromised individuals as well (3). While amplified nucleic acid hybridization probe assays for M. tuberculosis complex provide an important adjunct to the
diagnostic armamentarium, they have yet to displace traditional culture
(2, 4). Among mycobacterial culture detection systems, the
BACTEC 460 TB system has long been the standard against which
others are compared (5, 7). Newer methods that have recently
been developed, however, offer rapid TTD similar to that of the BACTEC
460 TB system while using fully automated, noninvasive, nonradiometric,
self-contained incubator readers, each with a capacity of 240 to 383 mycobacterial culture vials (10, 13, 14). In addition to the
automated instruments, the manual BBL MGIT system, which is a
fluorescent indicator broth method, provides similar rapid performance
characteristics, but without the need for any instrumentation other
than a UV light (15).
We evaluated the performance of the BACTEC MGIT 960, a high-capacity,
fully automated, noninvasive system for the growth and detection of
mycobacteria that requires neither radioactive media nor sharp
implements. We compared the BACTEC MGIT 960 to the BACTEC 460 TB system
and conventional solid media. Clearly, these data illustrate the
superior performance characteristics of the two BACTEC broth systems as
compared to solid media. Even though the LJ medium and two Middlebrook
media were counted together as a single system, only 250 (69%)
isolates of mycobacteria were recovered by using the combined solid
media. Despite the advantages of the broth-based cultivation systems,
traditional solid media still play a role in the recovery of
mycobacteria from clinical samples and are recommended for use along
with a liquid medium by the Centers for Disease Control (6).
In the present study, no one system recovered all isolates of either
M. tuberculosis complex or MAC. The highest overall recovery
rates were noted when solid media were combined with a liquid medium
system. It should be noted that 16 isolates (4%) were detected only in
the solid media, including 3 isolates of M. tuberculosis
complex. The variations in the concentrations of organisms in the
original specimens and the resulting random inoculum distribution among
the multiple culture systems under testing likely account for some of
these differences. Similarly, in a previous study of 1,184 respiratory specimens, no single medium tested provided the recovery of all isolates (12). In this study, among the three systems
tested, the BACTEC 12B provided the highest percentage of M. tuberculosis complex isolates recovered; the use of either 7H11
medium or LJ medium along with the 12B vial increased the recovery by 4 to 6%.
In the present study, the number of mycobacteria recovered in the
BACTEC MGIT 960 system was greater than those recovered in the BACTEC
460 TB system and with solid media. Among specimens collected at all
sites, 48% of the isolates detected were MAC, 36% were M. tuberculosis complex, and 16% were MOTT. In particular, the
BACTEC MGIT 960 detected more isolates of MAC and MOTT than did the
BACTEC 460 TB system. While a greater number of M. tuberculosis complex isolates were detected with the BACTEC 460 TB
than with the BACTEC MGIT 960, this advantage was almost exclusively
seen in smear-negative samples and was greatly diminished when solid media were added to the analysis. During the study, there were 11 specimens (10 of which were AFB smear negative) where the BACTEC MGIT
960 vial was found to have breakthrough contamination while M. tuberculosis complex was recovered from the BACTEC 460 TB vial. Conversely, there was only one specimen (AFB smear negative) for which
the BACTEC 460 TB vial was contaminated while an M. tuberculosis complex isolate was recovered from the BACTEC MGIT
960 vial. When these specimens were removed from the analysis, as shown
in Table 3, the recovery of M. tuberculosis complex with the
BACTEC MGIT 960 more closely approximated that of the BACTEC 460 TB
system. On the other hand, when specimens from which MAC was recovered from a cohort vial but the other was contaminated were removed from the
analysis, the superiority of the BACTEC MGIT 960, either with or
without solid media, remained significant.
In addition to overall recovery, the TTD is an important performance
characteristic of mycobacterial detection systems. When all isolates
recovered were included in the analysis, the TTD of M. tuberculosis complex with the BACTEC MGIT 960 (14.4 days) was
faster than that with the BACTEC 460 TB system (15.2 days). When only
the 92 paired isolates (recovered in both broth systems) were included
in the analysis, however, the TTD with the BACTEC 460 TB system (13.2 days) was faster than that with the BACTEC MGIT 960 (14.4 days). The
reason for this is apparent in Table 5, where all M. tuberculosis complex isolates recovered in each system are
separated according to smear result. The higher recovery rate of these
isolates in the BACTEC 460 TB system was almost exclusively due to
recovery from smear-negative specimens, which may be expected to have
fewer bacilli in the originating specimen and, concomitantly, a longer
mean TTD. As seen in Table 4, among the total AFB-containing samples,
the TTD recorded for the two BACTEC systems were essentially the same,
regardless of AFB smear result.
As a whole, the rate of breakthrough contamination was found to be
higher with the BACTEC MGIT 960 (8.1%) than with the BACTEC 460 TB
system (4.9%). There was, however, a large variation in the
contamination rate among the test sites for all the media tested. These
wide variations may reflect the dissimilar conditions of specimen
quality and transport time and conditions among the sites. Notably, at
two of the six test sites there was little difference in the rate of
contamination between the two systems, while at the other four sites,
contamination rates were clearly higher with the BACTEC MGIT 960 than
the BACTEC 460 TB system. This is similar to the experiences reported
when the ESP (13), MB/BacT System (10), BACTEC
9000MB (14), and BBL MGIT (15) were compared to
the BACTEC 460TB system. These higher rates of breakthrough
contamination are likely a result of the fact that the media in the
newer systems are more enriched than the BACTEC 460 TB media. The
BACTEC 12B medium relies on the metabolic utilization of radiolabeled
palmitic acid for the detection of 14C-labeled
CO2, signaling the presence of growing mycobacteria. Other
than the radiolabeled substrate, the 12B medium is very low in nutrient
content and is not an optimal growth environment for most bacteria,
which do not utilize the 14C substrate and thus are not detected.
The amounts of labor and user interaction required for efficient
operation are a substantial consideration in the selection of any
microbiology system. The BACTEC MGIT 960 system has very good
performance characteristics, is easy to use, and readily fits into the
customary mycobacteriology laboratory work flow. In large-volume
laboratories, the 960-culture tube capacity provides a decided
advantage over the continuously monitored instruments of lesser
capacity. When a 42-day protocol is used in a laboratory with a 10%
positivity rate, a single BACTEC MGIT 960 system could reasonably be
expected to accommodate at least 8,000 specimens per year.
In summary, the newly introduced BACTEC MGIT 960 system is a
dependable, high-capacity, compact, fully automated continuous monitoring instrument for the recovery of mycobacteria from human clinical samples. When used in combination with solid media, the BACTEC
MGIT 960 system shows performance comparable to that of the BACTEC 460 TB system for the detection of M. tuberculosis complex,
while providing greater recovery of MAC and MOTT.
 |
ACKNOWLEDGMENT |
This study was supported by Becton Dickinson Microbiology Systems.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Pathology, New York University School of Medicine, Bellevue 4W1, New York, NY 10016. Phone: (212) 263-6444. Fax: (212) 263-8284. E-mail: bah2{at}is2.nyu.edu.
 |
REFERENCES |
| 1.
|
Anhalt, J. P.,
F. G. Witebsky, and G. L. Woods.
1993.
College of American Pathologists position statement regarding rapid detection of Mycobacterium tuberculosis.
Arch. Pathol. Lab. Med.
117:873[Medline].
|
| 2.
|
Eing, B. R.,
A. Becker,
A. Sohns, and R. Ringelmann.
1998.
Comparison of Roche Cobas Amplicor Mycobacterium tuberculosis assay with in-house PCR and culture for detection of M. tuberculosis.
J. Clin. Microbiol.
36:2023-2029[Abstract/Free Full Text].
|
| 3.
|
Epstein, M. D.,
C. P. Aranda,
S. Bonk,
B. A. Hanna, and W. Rom.
1997.
The significance of Mycobacterium avium complex cultivation in the sputum of patients with pulmonary tuberculosis.
Chest
111:142-147[Abstract/Free Full Text].
|
| 4.
|
Gamboa, F.,
G. Fernandez,
E. Padilla,
J. M. Manterola,
J. Lonca,
P. J. Cardona,
L. Matas, and V. Ausina.
1998.
Comparative evaluation of initial and new versions of the Gen-Probe Amplified Mycobacterium Tuberculosis Direct Test for direct detection of Mycobacterium tuberculosis in respiratory and nonrespiratory specimens.
J. Clin. Microbiol.
36:684-689[Abstract/Free Full Text].
|
| 5.
|
Huebner, R. E.,
R. C. Good, and J. I. Tokars.
1993.
Current practices in mycobacteriology: results of a survey of state public health laboratories.
J. Clin. Microbiol.
31:771-775[Abstract/Free Full Text].
|
| 6.
|
Kent, P. T., and G. P. Kubica.
1985.
Public health mycobacteriology: a guide for the level III laboratory.
Department of Health and Human Services, Centers for Disease Control, Atlanta, Ga.
|
| 7.
|
Middlebrook, G.,
Z. Reggiardo, and W. D. Tigertt.
1977.
Automatic radiometric detection of growth of Mycobacterium tuberculosis in selective media.
Am. Rev. Respir. Dis.
115:1066-1069[Medline].
|
| 8.
|
Morgan, M. A.,
C. D. Horstmeier,
D. R. DeYoung, and G. D. Roberts.
1983.
Comparison of a radiometric method (BACTEC) and conventional culture media for recovery of mycobacteria from smear-negative specimens.
J. Clin. Microbiol.
18:384-388[Abstract/Free Full Text].
|
| 9.
|
Roberts, G. D.,
N. L. Goodman,
L. Heifets,
H. W. Larsh,
T. H. Lindner,
J. K. McClatchy,
M. R. McGinnis,
S. H. Siddiqi, and P. Wright.
1983.
Evaluation of the BACTEC radiometric method for recovery of mycobacteria and drug susceptibility testing of Mycobacterium tuberculosis from acid-fast smear-positive specimens.
J. Clin. Microbiol.
18:689-696[Abstract/Free Full Text].
|
| 10.
|
Rohner, P.,
B. Ninet,
C. Metral,
S. Emler, and R. Auckenthaler.
1997.
Evaluation of the MB/BacT system and comparison to the BACTEC 460 system and solid media for isolation of mycobacteria from clinical specimens.
J. Clin. Microbiol.
35:3127-3131[Abstract].
|
| 11.
|
Schluger, N. W., and W. N. Rom.
1994.
Current approaches to the diagnosis of active pulmonary tuberculosis.
Am. J. Respir. Crit. Care Med.
149:264-267[Medline].
|
| 12.
|
Stager, C. E.,
J. P. Libonati,
S. H. Siddiqi,
J. R. Davis,
N. M. Hooper,
J. F. Baker, and M. E. Carter.
1991.
Role of solid media when used in conjunction with the BACTEC system for mycobacterial isolation and identification.
J. Clin. Microbiol.
29:154-157[Abstract/Free Full Text].
|
| 13.
|
Tortoli, E.,
P. Cichero,
M. G. Chirillo,
M. R. Gismondo,
L. Bono,
G. Gesu,
M. T. Simonetti,
G. Volpe,
G. Nardi, and P. Marone.
1998.
Multicenter comparison of ESP Culture System II with BACTEC 460TB and with Lowenstein-Jensen medium for recovery of mycobacteria from different clinical specimens, including blood.
J. Clin. Microbiol.
36:1378-1381[Abstract/Free Full Text].
|
| 14.
|
Zanetti, S,
F. Ardito,
L. Sechi,
M. Sanguinetti,
P. Molicotti,
G. Delogu,
M. P. Pinna,
A. Nacci, and G. Fadda.
1997.
Evaluation of a nonradiometric system (BACTEC 9000MB) for detection of mycobacteria in human clinical samples.
J. Clin. Microbiol.
35:2072-2075[Abstract].
|
| 15.
|
Zuhre Badak, F.,
D. L. Kiska,
S. Setterquist,
C. Hartley,
M. A. O'Connell, and R. L. Hopfer.
1996.
Comparison of Mycobacteria Growth Indicator Tube with BACTEC 460 for detection and recovery of mycobacteria from clinical specimens.
J. Clin. Microbiol.
34:2236-2239[Abstract].
|
Journal of Clinical Microbiology, March 1999, p. 748-752, Vol. 37, No. 3
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Strassburg, A., Jafari, C., Ernst, M., Lotz, W., Lange, C.
(2008). Rapid diagnosis of pulmonary TB by BAL enzyme-linked immunospot assay in an immunocompromised host. Eur Respir J
31: 1132-1135
[Abstract]
[Full Text]
-
Marras, T. K, Chedore, P., Ying, A. M, Jamieson, F.
(2007). Isolation prevalence of pulmonary non-tuberculous mycobacteria in Ontario, 1997 2003. Thorax
62: 661-666
[Abstract]
[Full Text]
-
Mendelson, M.
(2007). Diagnosing tuberculosis in HIV-infected patients: challenges and future prospects. Br Med Bull
0: ldm009v1-17
[Abstract]
[Full Text]
-
Drobniewski, F. A., Hoffner, S., Rusch-Gerdes, S., Skenders, G., Thomsen, V., the WHO European Laboratory Strengthening Task For,
(2006). Recommended standards for modern tuberculosis laboratory services in Europe. Eur Respir J
28: 903-909
[Abstract]
[Full Text]
-
Hillemann, D., Richter, E., Rusch-Gerdes, S.
(2006). Use of the BACTEC Mycobacteria Growth Indicator Tube 960 Automated System for Recovery of Mycobacteria from 9,558 Extrapulmonary Specimens, Including Urine Samples. J. Clin. Microbiol.
44: 4014-4017
[Abstract]
[Full Text]
-
Jafari, C., Ernst, M., Kalsdorf, B., Greinert, U., Diel, R., Kirsten, D., Marienfeld, K., Lalvani, A., Lange, C.
(2006). Rapid Diagnosis of Smear-negative Tuberculosis by Bronchoalveolar Lavage Enzyme-linked Immunospot. Am. J. Respir. Crit. Care Med.
174: 1048-1054
[Abstract]
[Full Text]
-
Adekambi, T., Reynaud-Gaubert, M., Greub, G., Gevaudan, M.-J., La Scola, B., Raoult, D., Drancourt, M.
(2004). Amoebal Coculture of "Mycobacterium massiliense" sp. nov. from the Sputum of a Patient with Hemoptoic Pneumonia. J. Clin. Microbiol.
42: 5493-5501
[Abstract]
[Full Text]
-
Richter, E., Weizenegger, M., Fahr, A.-M., Rusch-Gerdes, S.
(2004). Usefulness of the GenoType MTBC Assay for Differentiating Species of the Mycobacterium tuberculosis Complex in Cultures Obtained from Clinical Specimens. J. Clin. Microbiol.
42: 4303-4306
[Abstract]
[Full Text]
-
Johansen, I. S., Thomsen, V. O., Forsgren, A., Hansen, B. F., Lundgren, B.
(2004). Detection of Mycobacterium tuberculosis Complex in Formalin-Fixed, Paraffin-Embedded Tissue Specimens with Necrotizing Granulomatous Inflammation by Strand Displacement Amplification. J. Mol. Diagn.
6: 231-236
[Abstract]
[Full Text]
-
Cruciani, M., Scarparo, C., Malena, M., Bosco, O., Serpelloni, G., Mengoli, C.
(2004). Meta-Analysis of BACTEC MGIT 960 and BACTEC 460 TB, with or without Solid Media, for Detection of Mycobacteria. J. Clin. Microbiol.
42: 2321-2325
[Abstract]
[Full Text]
-
Somoskovi, A., Song, Q., Mester, J., Tanner, C., Hale, Y. M., Parsons, L. M., Salfinger, M.
(2003). Use of Molecular Methods To Identify the Mycobacterium tuberculosis Complex (MTBC) and Other Mycobacterial Species and To Detect Rifampin Resistance in MTBC Isolates following Growth Detection with the BACTEC MGIT 960 System. J. Clin. Microbiol.
41: 2822-2826
[Abstract]
[Full Text]
-
Adjers-Koskela, K., Katila, M.-L.
(2003). Susceptibility Testing with the Manual Mycobacteria Growth Indicator Tube (MGIT) and the MGIT 960 System Provides Rapid and Reliable Verification of Multidrug-Resistant Tuberculosis. J. Clin. Microbiol.
41: 1235-1239
[Abstract]
[Full Text]
-
Romano, L., Sanguinetti, M., Posteraro, B., Ardito, F., Gesu, G., Schito, A. M., Fadda, G.
(2002). Early Detection of Negative BACTEC MGIT 960 Cultures by PCR-Reverse Cross-Blot Hybridization Assay. J. Clin. Microbiol.
40: 3499-3501
[Abstract]
[Full Text]
-
Huang, T.-S., Tu, H.-Z., Lee, S. S.-J., Huang, W.-K., Liu, Y.-C.
(2002). Antimicrobial Susceptibility Testing of Mycobacterium tuberculosis to First-Line Drugs: Comparisons of the MGIT 960 and BACTEC 460 Systems. Annals of Clinical & Laboratory Science
32: 142-147
[Abstract]
[Full Text]
-
Ardito, F., Posteraro, B., Sanguinetti, M., Zanetti, S., Fadda, G.
(2001). Evaluation of BACTEC Mycobacteria Growth Indicator Tube (MGIT 960) Automated System for Drug Susceptibility Testing of Mycobacterium tuberculosis. J. Clin. Microbiol.
39: 4440-4444
[Abstract]
[Full Text]
-
Banaiee, N., Bobadilla-del-Valle, M., Bardarov, S. Jr., Riska, P. F., Small, P. M., Ponce-de-Leon, A., Jacobs, W. R. Jr., Hatfull, G. F., Sifuentes-Osornio, J.
(2001). Luciferase Reporter Mycobacteriophages for Detection, Identification, and Antibiotic Susceptibility Testing of Mycobacterium tuberculosis in Mexico. J. Clin. Microbiol.
39: 3883-3888
[Abstract]
[Full Text]
-
Leitritz, L., Schubert, S., Bucherl, B., Masch, A., Heesemann, J., Roggenkamp, A.
(2001). Evaluation of BACTEC MGIT 960 and BACTEC 460TB Systems for Recovery of Mycobacteria from Clinical Specimens of a University Hospital with Low Incidence of Tuberculosis. J. Clin. Microbiol.
39: 3764-3767
[Abstract]
[Full Text]
-
Huang, T.-S., Chen, C.-S., Lee, S. S.-J., Huang, W.-K., Liu, Y.-C.
(2001). Comparison of the BACTEC MGIT 960 and BACTEC 460TB Systems for Detection of Mycobacteria in Clinical Specimens. Annals of Clinical & Laboratory Science
31: 279-283
[Abstract]
[Full Text]
-
Hongmanee, P., Stender, H., Rasmussen, O. F.
(2001). Evaluation of a Fluorescence In Situ Hybridization Assay for Differentiation between Tuberculous and Nontuberculous Mycobacterium Species in Smears of Lowenstein-Jensen and Mycobacteria Growth Indicator Tube Cultures Using Peptide Nucleic Acid Probes. J. Clin. Microbiol.
39: 1032-1035
[Abstract]
[Full Text]
-
Gascoyne-Binzi, D. M., Barlow, R. E. L., Frothingham, R., Robinson, G., Collyns, T. A., Gelletlie, R., Hawkey, P. M.
(2001). Rapid Identification of Laboratory Contamination with Mycobacterium tuberculosis Using Variable Number Tandem Repeat Analysis. J. Clin. Microbiol.
39: 69-74
[Abstract]
[Full Text]
-
Williams-Bouyer, N., Yorke, R., Lee, H. I., Woods, G. L.
(2000). Comparison of the BACTEC MGIT 960 and ESP Culture System II for Growth and Detection of Mycobacteria. J. Clin. Microbiol.
38: 4167-4170
[Abstract]
[Full Text]
-
Watterson, S A, Drobniewski, F A
(2000). Modern laboratory diagnosis of mycobacterial infections. J. Clin. Pathol.
53: 727-732
[Abstract]
[Full Text]
-
Whyte, T., Hanahoe, B., Collins, T., Corbett-Feeney, G., Cormican;, M., Alcaide, F., Benítez, M. A., Martín, R., Escribà, J. M.
(2000). Evaluation of the BACTEC MGIT 960 and MB BAC/T Systems for Routine Detection of Mycobacterium tuberculosis. J. Clin. Microbiol.
38: 3131-3132
[Full Text]
-
Somoskövi, A., Ködmön, C., Lantos, A., Bártfai, Z., Tamási, L., Füzy, J., Magyar, P.
(2000). Comparison of Recoveries of Mycobacterium tuberculosis Using the Automated BACTEC MGIT 960 System, the BACTEC 460 TB System, and Lowenstein-Jensen Medium. J. Clin. Microbiol.
38: 2395-2397
[Abstract]
[Full Text]
-
Katila, M.-L., Katila, P., Erkinjuntti-Pekkanen, R.
(2000). Accelerated Detection and Identification of Mycobacteria with MGIT 960 and COBAS AMPLICOR Systems. J. Clin. Microbiol.
38: 960-964
[Abstract]
[Full Text]
-
Alcaide, F., Benítez, M. A., Escribà, J. M., Martín, R.
(2000). Evaluation of the BACTEC MGIT 960 and the MB/BacT Systems for Recovery of Mycobacteria from Clinical Specimens and for Species Identification by DNA AccuProbe. J. Clin. Microbiol.
38: 398-401
[Abstract]
[Full Text]
-
Tortoli, E., Cichero, P., Piersimoni, C., Simonetti, M. T., Gesu, G., Nista, D.
(1999). Use of BACTEC MGIT 960 for Recovery of Mycobacteria from Clinical Specimens: Multicenter Study. J. Clin. Microbiol.
37: 3578-3582
[Abstract]
[Full Text]